Molina R - Search Results

1

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.

Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM. Molina R, et al. Anticancer Res. 2005 May-Jun;25(3A):1773-8. Anticancer Res. 2005. PMID: 16033098 Free article.

2

Pro-gastrin-releasing peptide in patients with benign and malignant diseases.

Molina R, Auge JM, Alicarte J, Filella X, Viñolas N, Ballesta AM. Molina R, et al. Tumour Biol. 2004 Jan-Apr;25(1-2):56-61. doi: 10.1159/000077724. Tumour Biol. 2004. PMID: 15192313

3

ProGRP: a new biomarker for small cell lung cancer.

Molina R, Filella X, Augé JM. Molina R, et al. Clin Biochem. 2004 Jul;37(7):505-11. doi: 10.1016/j.clinbiochem.2004.05.007. Clin Biochem. 2004. PMID: 15234231 Review.

4

Complexed prostate-specific antigen for the detection of prostate cancer.

Filella X, Truan D, Alcover J, Gutierrez R, Molina R, Coca F, Ballesta AM. Filella X, et al. Among authors: molina r. Anticancer Res. 2004 Nov-Dec;24(6):4181-5. Anticancer Res. 2004. PMID: 15736470 Free article.

5

CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.

Molina R, Filella X, Augé JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A. Molina R, et al. Anticancer Res. 2005 May-Jun;25(3A):1765-71. Anticancer Res. 2005. PMID: 16033097 Free article.

6

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.

Molina R, Auge JM, Escudero JM, Marrades R, Viñolas N, Carcereny E, Ramirez J, Filella X. Molina R, et al. Tumour Biol. 2008;29(6):371-80. doi: 10.1159/000181180. Epub 2008 Dec 8. Tumour Biol. 2008. PMID: 19060513

7

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Molina R, Augé JM, Bosch X, Escudero JM, Viñolas N, Marrades R, Ramírez J, Carcereny E, Filella X. Molina R, et al. Tumour Biol. 2009;30(3):121-9. doi: 10.1159/000224628. Epub 2009 Jun 9. Tumour Biol. 2009. PMID: 19506400

8

Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value.

Molina R, Augé JM, Escudero JM, Filella X, Zanon G, Pahisa J, Farrus B, Muñoz M, Velasco M. Molina R, et al. Tumour Biol. 2010 Jun;31(3):171-80. doi: 10.1007/s13277-010-0025-9. Epub 2010 Apr 2. Tumour Biol. 2010. PMID: 20361287

9

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.

Escudero JM, Auge JM, Filella X, Torne A, Pahisa J, Molina R. Escudero JM, et al. Among authors: molina r. Clin Chem. 2011 Nov;57(11):1534-44. doi: 10.1373/clinchem.2010.157073. Epub 2011 Sep 20. Clin Chem. 2011. PMID: 21933899

10

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

Molina R, Marrades RM, Augé JM, Escudero JM, Viñolas N, Reguart N, Ramirez J, Filella X, Molins L, Agustí A. Molina R, et al. Am J Respir Crit Care Med. 2016 Feb 15;193(4):427-37. doi: 10.1164/rccm.201404-0603OC. Am J Respir Crit Care Med. 2016. PMID: 26465739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,163 results

Search Page

Filters